Atlas Trials

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

Clinical trial NCT00224315 · COMPLETED

Trial details

NCT number
NCT00224315
Sponsor
Central Institute of Mental Health, Mannheim
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Schizophrenia, Schizoaffective Disorder
Start date
2003-11-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.